Skip to main content


Page 3 of 15

  1. There is still no approved medication for the core symptoms of autism spectrum disorder (ASD). This network meta-analysis investigated pharmacological and dietary-supplement treatments for ASD.

    Authors: Spyridon Siafis, Oğulcan Çıray, Hui Wu, Johannes Schneider-Thoma, Irene Bighelli, Marc Krause, Alessandro Rodolico, Anna Ceraso, Giacomo Deste, Maximilian Huhn, David Fraguas, Antonia San José Cáceres, Dimitris Mavridis, Tony Charman, Declan G. Murphy, Mara Parellada…
    Citation: Molecular Autism 2022 13:10
  2. Clinical and etiological varieties remain major obstacles to decompose heterogeneity in autism spectrum disorders (ASD). Recently, neuroimaging raised new hope to identify neurosubtypes of ASD for further unde...

    Authors: Guanlu Liu, Liting Shi, Jianfeng Qiu and Weizhao Lu
    Citation: Molecular Autism 2022 13:9
  3. A significant proportion of variation in likelihood of neurodevelopmental conditions (NDCs) has been attributed to nonshared environmental (NSE) factors, although it remains unclear which NSE factors pose spec...

    Authors: Johan Isaksson, Vladislav Ruchkin, Nikolas Aho, Karl Lundin Remnélius, Peter B. Marschik and Sven Bölte
    Citation: Molecular Autism 2022 13:8
  4. Autistic adults, particularly women, are more likely to experience chronic ill health than the general population. Central sensitivity syndromes (CSS) are a group of related conditions that are thought to incl...

    Authors: Sarah Grant, Sam Norton, Ricarda F. Weiland, Anke M. Scheeren, Sander Begeer and Rosa A. Hoekstra
    Citation: Molecular Autism 2022 13:7
  5. Phelan–McDermid syndrome (PMS) is caused by 22q13 deletions including SHANK3 or pathogenic sequence variants in SHANK3 and is among the more common rare genetic findings in autism spectrum disorder (ASD). SHANK3 ...

    Authors: S. Sethuram, T. Levy, J. Foss-Feig, D. Halpern, S. Sandin, P. M. Siper, H. Walker, J. D. Buxbaum, R. Rapaport and A. Kolevzon
    Citation: Molecular Autism 2022 13:6
  6. Autistic individuals frequently experience social communication challenges. Girls are diagnosed with autism less often than boys even when their symptoms are equally severe, which may be due to insufficient un...

    Authors: Meredith Cola, Lisa D. Yankowitz, Kimberly Tena, Alison Russell, Leila Bateman, Azia Knox, Samantha Plate, Laura S. Cubit, Casey J. Zampella, Juhi Pandey, Robert T. Schultz and Julia Parish-Morris
    Citation: Molecular Autism 2022 13:5
  7. Authors: Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, Tiziana Zalla, Daniel Umbricht, Christopher Chatham, Lorraine Murtagh, Josselin Houenou, Richard Delorme, Myriam Ly-Le Moal, Marion Leboyer, Manuel Bouvard and Jean-René Cazalets
    Citation: Molecular Autism 2022 13:4

    The original article was published in Molecular Autism 2021 12:71

  8. Existing research has demonstrated elevated autistic behaviours in children with neurofibromatosis type 1 (NF1), but the autistic phenotype and its relationship to other neurodevelopmental manifestations of NF...

    Authors: Anita K. Chisholm, Kristina M. Haebich, Natalie A. Pride, Karin S. Walsh, Francesca Lami, Alex Ure, Tiba Maloof, Amanda Brignell, Melissa Rouel, Yael Granader, Alice Maier, Belinda Barton, Hayley Darke, Gabriel Dabscheck, Vicki A. Anderson, Katrina Williams…
    Citation: Molecular Autism 2022 13:3
  9. Autism screening is recommended at 18- and 24-month pediatric well visits. The Modified Checklist for Autism in Toddlers—Revised (M-CHAT-R) authors recommend a follow-up interview (M-CHAT-R/F) when positive. M...

    Authors: Raymond Sturner, Barbara Howard, Paul Bergmann, Shana Attar, Lydia Stewart-Artz, Kerry Bet, Carrie Allison and Simon Baron-Cohen
    Citation: Molecular Autism 2022 13:2
  10. Dravet Syndrome is a severe childhood pharmaco-resistant epileptic disorder mainly caused by mutations in the SCN1A gene, which encodes for the α1 subunit of the type I voltage-gated sodium channel (NaV1.1), that...

    Authors: Stefania Beretta, Laura Gritti, Luisa Ponzoni, Paolo Scalmani, Massimo Mantegazza, Mariaelvina Sala, Chiara Verpelli and Carlo Sala
    Citation: Molecular Autism 2022 13:1
  11. The neurocognitive mechanisms underlying autism spectrum disorder (ASD) remain unclear. Progress has been largely hampered by small sample sizes, variable age ranges and resulting inconsistent findings. There ...

    Authors: L. Mason, F. Shic, T. Falck-Ytter, B. Chakrabarti, T. Charman, E. Loth, J. Tillmann, T. Banaschewski, S. Baron-Cohen, S. Bölte, J. Buitelaar, S. Durston, B. Oranje, A. M. Persico, C. Beckmann, T. Bougeron…
    Citation: Molecular Autism 2021 12:74
  12. Autism is a developmental condition, where symptoms are expected to occur in childhood, but a significant number of individuals are diagnosed with autism for the first time in adulthood. Here, we examine diagn...

    Authors: Eya-Mist Rødgaard, Kristian Jensen, Kamilla Woznica Miskowiak and Laurent Mottron
    Citation: Molecular Autism 2021 12:73
  13. Anxiety is prevalent in autism spectrum disorder (ASD) and can negatively impact physical and mental health. Self-awareness of anxiety signs is a key barrier to success of anxiety interventions for many children.

    Authors: Jenny Nguyen, Robyn E. Cardy, Evdokia Anagnostou, Jessica Brian and Azadeh Kushki
    Citation: Molecular Autism 2021 12:72
  14. Inhibitory control and attention processing atypicalities are implicated in various diseases, including autism spectrum disorders (ASD). These cognitive functions can be tested by using visually guided saccade...

    Authors: Anouck Amestoy, Etienne Guillaud, Giulia Bucchioni, Tiziana Zalla, Daniel Umbricht, Christopher Chatham, Lorraine Murtagh, Josselin Houenou, Richard Delorme, Myriam Ly-Le Moal, Marion Leboyer, Manuel Bouvard and Jean-René Cazalets
    Citation: Molecular Autism 2021 12:71

    The Correction to this article has been published in Molecular Autism 2022 13:4

  15. De novo variants in the voltage-gated calcium channel subunit α1 E gene (CACNA1E) have been described as causative of epileptic encephalopathy with contractures, macrocephaly and dyskinesias.

    Authors: Beryl Royer-Bertrand, Marine Jequier Gygax, Katarina Cisarova, Jill A. Rosenfeld, Jennifer A. Bassetti, Oana Moldovan, Emily O’Heir, Lindsay C. Burrage, Jake Allen, Lisa T. Emrick, Emma Eastman, Camille Kumps, Safdar Abbas, Geraldine Van Winckel, Nadia Chabane, Elaine H. Zackai…
    Citation: Molecular Autism 2021 12:69
  16. Immune system dysfunction has been proposed to play a critical role in the pathophysiology of autism spectrum disorders (ASD). Conflicting reports of lymphocyte subpopulation abnormalities have been described ...

    Authors: Pierre Ellul, Michelle Rosenzwajg, Hugo Peyre, Gwladys Fourcade, Encarnita Mariotti-Ferrandiz, Vincent Trebossen, David Klatzmann and Richard Delorme
    Citation: Molecular Autism 2021 12:68
  17. Atypical reactions to the sensory environment are often reported in autistic individuals, with a high degree of variability across the sensory modalities. These sensory differences have been shown to promote c...

    Authors: Nichole E. Scheerer, Kristina Curcin, Bobby Stojanoski, Evdokia Anagnostou, Rob Nicolson, Elizabeth Kelley, Stelios Georgiades, Xudong Liu and Ryan A. Stevenson
    Citation: Molecular Autism 2021 12:67
  18. Genetic studies have implicated rare and common variations in liability for autism spectrum disorder (ASD). Of the discovered risk variants, those rare in the population invariably have large impact on liabili...

    Authors: Lambertus Klei, Lora Lee McClain, Behrang Mahjani, Klea Panayidou, Silvia De Rubeis, Anna-Carin Säll Grahnat, Gun Karlsson, Yangyi Lu, Nadine Melhem, Xinyi Xu, Abraham Reichenberg, Sven Sandin, Christina M. Hultman, Joseph D. Buxbaum, Kathryn Roeder and Bernie Devlin
    Citation: Molecular Autism 2021 12:66
  19. The Autism Sequencing Consortium identified 102 high-confidence autism spectrum disorder (ASD) genes, showing that individuals with ASD and with potentially damaging single nucleotide variation (pdSNV) in thes...

    Authors: Behrang Mahjani, Silvia De Rubeis, Christina Gustavsson Mahjani, Maureen Mulhern, Xinyi Xu, Lambertus Klei, F. Kyle Satterstrom, Jack Fu, Michael E. Talkowski, Abraham Reichenberg, Sven Sandin, Christina M. Hultman, Dorothy E. Grice, Kathryn Roeder, Bernie Devlin and Joseph D. Buxbaum
    Citation: Molecular Autism 2021 12:65
  20. According to Bayesian hypotheses, individuals with Autism Spectrum Disorder (ASD) have difficulties making accurate predictions about their environment. In particular, the mechanisms by which they assign preci...

    Authors: Laurie-Anne Sapey-Triomphe, Joke Temmerman, Nicolaas A. J. Puts and Johan Wagemans
    Citation: Molecular Autism 2021 12:64
  21. The majority of research examining emotional difficulties in autism spectrum disorder (ASD) prior to age 2 relies on parent report.

    Authors: Lori-Ann R. Sacrey, Lonnie Zwaigenbaum, Jessica A. Brian, Isabel M. Smith, Vickie Armstrong, Sarah Raza, Tracy Vaillancourt and Louis A. Schmidt
    Citation: Molecular Autism 2021 12:63
  22. Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the SHANK3 gene and characterized by global developmental delays, deficits in speech and motor function, and au...

    Authors: J. Fastman, J. Foss-Feig, Y. Frank, D. Halpern, H. Harony-Nicolas, C. Layton, S. Sandin, P. Siper, L. Tang, P. Trelles, J. Zweifach, J. D. Buxbaum and A. Kolevzon
    Citation: Molecular Autism 2021 12:62
  23. FOXP1 syndrome is an autosomal dominant neurodevelopmental disorder characterized by intellectual disability, developmental delay, speech and language delays, and externalizing behaviors. We previously evaluat...

    Authors: M. Pilar Trelles, Tess Levy, Bonnie Lerman, Paige Siper, Reymundo Lozano, Danielle Halpern, Hannah Walker, Jessica Zweifach, Yitzchak Frank, Jennifer Foss-Feig, Alexander Kolevzon and Joseph Buxbaum
    Citation: Molecular Autism 2021 12:61
  24. Fever during pregnancy is a relatively common and most often trivial event. However, under specific conditions, it could affect significantly fetal brain development. Few studies, with inconsistent results, in...

    Authors: Stephanie Antoun, Pierre Ellul, Hugo Peyre, Michelle Rosenzwajg, Pierre Gressens, David Klatzmann and Richard Delorme
    Citation: Molecular Autism 2021 12:60
  25. Angelman Syndrome (AS) is a rare neurodevelopmental disorder for which there is currently no cure or effective therapeutic. Since the genetic cause of AS is known to be dysfunctional expression of the maternal...

    Authors: Elizabeth L. Berg, Stela P. Petkova, Heather A. Born, Anna Adhikari, Anne E. Anderson and Jill L. Silverman
    Citation: Molecular Autism 2021 12:59
  26. Restricted and repetitive behavior (RRB) is one of the characteristic features of Autism Spectrum Disorder. This domain of symptoms includes a broad range of behaviors. There is a need to study each behavior i...

    Authors: V. Courchesne, R. Bedford, A. Pickles, E. Duku, C. Kerns, P. Mirenda, T. Bennett, S. Georgiades, I. M. Smith, W. J. Ungar, T. Vaillancourt, A. Zaidman-Zait, L. Zwaigenbaum, P. Szatmari and M. Elsabbagh
    Citation: Molecular Autism 2021 12:57
  27. Alexithymia, a personality trait characterized by difficulties interpreting emotional states, is commonly elevated in autistic adults, and a growing body of literature suggests that this trait underlies severa...

    Authors: Zachary J. Williams and Katherine O. Gotham
    Citation: Molecular Autism 2021 12:56
  28. ASD and ADHD are prevalent neurodevelopmental disorders that frequently co-occur and have strong evidence for a degree of shared genetic aetiology. Behavioural and neurocognitive heterogeneity in ASD and ADHD ...

    Authors: Rachael Knott, Beth P. Johnson, Jeggan Tiego, Olivia Mellahn, Amy Finlay, Kathryn Kallady, Maria Kouspos, Vishnu Priya Mohanakumar Sindhu, Ziarih Hawi, Aurina Arnatkeviciute, Tracey Chau, Dalia Maron, Emily-Clare Mercieca, Kirsten Furley, Katrina Harris, Katrina Williams…
    Citation: Molecular Autism 2021 12:55
  29. Sleep disturbances in autism spectrum disorder (ASD) represent a common and vexing comorbidity. Clinical heterogeneity amongst these warrants studies of the mechanisms associated with specific genetic etiologi...

    Authors: Vidya Saravanapandian, Divya Nadkarni, Sheng-Hsiou Hsu, Shaun A. Hussain, Kiran Maski, Peyman Golshani, Christopher S. Colwell, Saravanavel Balasubramanian, Amos Dixon, Daniel H. Geschwind and Shafali S. Jeste
    Citation: Molecular Autism 2021 12:54
  30. RASopathies are a group of disorders that result from mutations in genes coding for proteins involved in regulating the Ras-MAPK signaling pathway, and have an increased incidence of autism spectrum disorder (...

    Authors: Sarah C. Borrie, Ellen Plasschaert, Zsuzsanna Callaerts-Vegh, Akihiko Yoshimura, Rudi D’Hooge, Ype Elgersma, Steven A. Kushner, Eric Legius and Hilde Brems
    Citation: Molecular Autism 2021 12:53
  31. Sensorimotor issues are common in autism spectrum disorder (ASD), related to core symptoms, and predictive of worse functional outcomes. Deficits in rapid behaviors supported primarily by feedforward mechanism...

    Authors: Kathryn E. Unruh, Walker S. McKinney, Erin K. Bojanek, Kandace K. Fleming, John A. Sweeney and Matthew W. Mosconi
    Citation: Molecular Autism 2021 12:52
  32. Prenatal sex steroids have been associated with autism in several clinical and epidemiological studies. It is unclear how this relates to the autistic traits of the mother and how early this can be detected du...

    Authors: A. Tsompanidis, E. Aydin, E. Padaigaitė, G. Richards, C. Allison, G. Hackett, T. Austin, R. Holt and S. Baron-Cohen
    Citation: Molecular Autism 2021 12:51
  33. Rhesus monkeys (Macaca mulatta) exhibit pronounced individual differences in social traits as measured by the macaque Social Responsiveness Scale-Revised. The macaque Social Responsiveness Scale was previously ad...

    Authors: Ozge Oztan, Catherine F. Talbot, Emanuela Argilli, Alyssa C. Maness, Sierra M. Simmons, Noreen Mohsin, Laura A. Del Rosso, Joseph P. Garner, Elliott H. Sherr, John P. Capitanio and Karen J. Parker
    Citation: Molecular Autism 2021 12:50
  34. Autism spectrum disorder (ASD) has a high cost to affected individuals and society, but treatments for core symptoms are lacking. To expand intervention options, it is crucial to gain a better understanding of...

    Authors: Charlotte M. Pretzsch, Dorothea L. Floris, Bogdan Voinescu, Malka Elsahib, Maria A. Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Elise Pretzsch, Steven Williams, Declan G. M. Murphy, Eileen Daly and Gráinne M. McAlonan
    Citation: Molecular Autism 2021 12:49
  35. Evidences suggesting the association between behavioral anomalies in autism and white matter (WM) microstructural alterations are increasing. Diffusion tensor imaging (DTI) is widely used to infer tissue micro...

    Authors: Christina Andica, Koji Kamagata, Eiji Kirino, Wataru Uchida, Ryusuke Irie, Syo Murata and Shigeki Aoki
    Citation: Molecular Autism 2021 12:48
  36. Recent research suggests a link between autism spectrum disorder (ASD) and anorexia nervosa (AN). Individuals with AN show high scores on measures of ASD symptoms, relative to individuals without AN, however, ...

    Authors: Jess Kerr-Gaffney, Hannah Hayward, Emily J. H. Jones, Daniel Halls, Declan Murphy and Kate Tchanturia
    Citation: Molecular Autism 2021 12:47
  37. Autistic people and those with high autistic traits are at high risk of experiencing suicidality. Yet, there are no suicidality assessment tools developed or validated for these groups.

    Authors: Sarah A. Cassidy, Louise Bradley, Heather Cogger-Ward and Jacqui Rodgers
    Citation: Molecular Autism 2021 12:46
  38. Authors: Andrew W. Zimmerman, Kanwaljit Singh, Susan L. Connors, Hua Liu, Anita A. Panjwani, Li‑Ching Lee, Eileen Diggins, Ann Foley, Stepan Melnyk, Indrapal N. Singh, S. Jill James, Richard E. Frye and Jed W. Fahey
    Citation: Molecular Autism 2021 12:44

    The original article was published in Molecular Autism 2021 12:38

  39. Neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) display a strong male bias. Androgen exposure is profoundly increased in typical male development, but it also varies within the sexes...

    Authors: Brooke G. McKenna, Yongchao Huang, Kévin Vervier, Dabney Hofammann, Mary Cafferata, Seima Al-Momani, Florencia Lowenthal, Angela Zhang, Jin-Young Koh, Savantha Thenuwara, Leo Brueggeman, Ethan Bahl, Tanner Koomar, Natalie Pottschmidt, Taylor Kalmus, Lucas Casten…
    Citation: Molecular Autism 2021 12:43
  40. Individuals on the autism spectrum are reported to display alterations in interoception, the sense of the internal state of the body. The Interoception Sensory Questionnaire (ISQ) is a 20-item self-report meas...

    Authors: Evan Suzman, Zachary J. Williams, Jacob I. Feldman, Michelle Failla, Carissa J. Cascio, Mark T. Wallace, Maria Niarchou, James S. Sutcliffe, Ericka Wodka and Tiffany G. Woynaroski
    Citation: Molecular Autism 2021 12:42
  41. Autism spectrum disorder (ASD) has a strong genetic etiology. Germline mutation in the tumor suppressor gene PTEN is one of the best described monogenic risk cases for ASD. Animal modeling of cell-specific Pten l...

    Authors: Nick Sarn, Stetson Thacker, Hyunpil Lee and Charis Eng
    Citation: Molecular Autism 2021 12:41
  42. This article has been retracted. Please see the Retraction Notice for more detail:

    Authors: Zachary J. Williams and Katherine O. Gotham
    Citation: Molecular Autism 2021 12:40

    The original article was published in Molecular Autism 2021 12:20

  43. Restricted and repetitive behaviors (RRB) in autism spectrum disorder (ASD) encompass several distinct domains. However, commonly used general ASD measures provide broad RRB scores rather than assessing separa...

    Authors: Mirko Uljarević, Booil Jo, Thomas W. Frazier, Lawrence Scahill, Eric A. Youngstrom and Antonio Y. Hardan
    Citation: Molecular Autism 2021 12:39
  44. Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials o...

    Authors: Andrew W. Zimmerman, Kanwaljit Singh, Susan L. Connors, Hua Liu, Anita A. Panjwani, Li-Ching Lee, Eileen Diggins, Ann Foley, Stepan Melnyk, Indrapal N. Singh, S. Jill James, Richard E. Frye and Jed W. Fahey
    Citation: Molecular Autism 2021 12:38

    The Correction to this article has been published in Molecular Autism 2021 12:44

  45. Traits and characteristics qualitatively similar to those seen in diagnosed autism spectrum disorder can be found to varying degrees in the general population. To measure these traits and facilitate their use ...

    Authors: Michael C. W. English, Gilles E. Gignac, Troy A. W. Visser, Andrew J. O. Whitehouse, James T. Enns and Murray T. Maybery
    Citation: Molecular Autism 2021 12:37

    The Correction to this article has been published in Molecular Autism 2021 12:70

  46. DDX3X syndrome is a recently identified genetic disorder that accounts for 1–3% of cases of unexplained developmental delay and/or intellectual disability (ID) in females, and is associated with motor and lang...

    Authors: Lara Tang, Tess Levy, Sylvia Guillory, Danielle Halpern, Jessica Zweifach, Ivy Giserman-Kiss, Jennifer H. Foss-Feig, Yitzchak Frank, Reymundo Lozano, Puneet Belani, Christina Layton, Bonnie Lerman, Emanuel Frowner, Michael S. Breen, Silvia De Rubeis, Ana Kostic…
    Citation: Molecular Autism 2021 12:36
  47. Language delay is one of the major referral criteria for an autism evaluation. Once an autism spectrum diagnosis is established, the language prognosis is among the main parental concerns. Early language regre...

    Authors: David Gagnon, Abderrahim Zeribi, Élise Douard, Valérie Courchesne, Borja Rodríguez-Herreros, Guillaume Huguet, Sébastien Jacquemont, Mor Absa Loum and Laurent Mottron
    Citation: Molecular Autism 2021 12:35

Annual Journal Metrics

  • 2022 Citation Impact
    6.2 - 2-year Impact Factor
    7.2 - 5-year Impact Factor
    1.690 - SNIP (Source Normalized Impact per Paper)
    1.647 - SJR (SCImago Journal Rank)

    2022 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    133 days submission to accept (Median)

    2022 Usage 
    12,911 Altmetric mentions